Guggenheim Capital LLC Amphastar Pharmaceuticals, Inc. Transaction History

Guggenheim Capital LLC

  • $14 Billion
  • Q3 2024

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$38.65 - $43.48 $60,796 - $68,394
1,573 Added 34.11%
6,184 $247,000
Q1 2024

May 14, 2024
BUY
$42.85 - $63.45 $5,699 - $8,438
133 Added 2.97%
4,611 $202,000
Q4 2023

Feb 14, 2024
SELL
$44.49 - $62.93 $69,893 - $98,863
-1,571 Reduced 25.97%
4,478 $276,000
Q3 2023

Nov 14, 2023
SELL
$45.51 - $65.0 $3,549 - $5,070
-78 Reduced 1.27%
6,049 $278,000
Q2 2023

Aug 11, 2023
SELL
$35.77 - $58.38 $205,284 - $335,042
-5,739 Reduced 48.37%
6,127 $352,000
Q1 2023

May 10, 2023
SELL
$27.99 - $37.92 $176,420 - $239,009
-6,303 Reduced 34.69%
11,866 $444,000
Q4 2022

Feb 14, 2023
BUY
$27.93 - $31.27 $114,401 - $128,081
4,096 Added 29.11%
18,169 $509,000
Q3 2022

Nov 14, 2022
SELL
$27.56 - $37.75 $32,272 - $44,205
-1,171 Reduced 7.68%
14,073 $395,000
Q2 2022

Aug 15, 2022
SELL
$29.79 - $42.29 $473,988 - $672,876
-15,911 Reduced 51.07%
15,244 $531,000
Q1 2022

May 16, 2022
SELL
$22.96 - $36.45 $69,706 - $110,662
-3,036 Reduced 8.88%
31,155 $1.12 Million
Q4 2021

Feb 14, 2022
SELL
$18.14 - $23.29 $51,971 - $66,725
-2,865 Reduced 7.73%
34,191 $796,000
Q3 2021

Nov 15, 2021
BUY
$17.83 - $21.49 $660,708 - $796,333
37,056 New
37,056 $704,000

Others Institutions Holding AMPH

# of Institutions
286
Shares Held
34.9M
Call Options Held
74.3K
Put Options Held
22.3K
View Full List

About Amphastar Pharmaceuticals, Inc.

AMPH Quotes by TradingView
  • Ticker AMPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,015,200
  • Market Cap $1.92B
  • Description
  • Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...
More about AMPH
Track This Portfolio

Track Guggenheim Capital LLC Portfolio

Follow Guggenheim Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guggenheim Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email